Signature Wealth Management Partners, LLC Gilead Sciences, Inc. Transaction History

Signature Wealth Management Partners, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 02, 2023	SELL	$77.31 - $88.08 $77,310 - $88,080	-1,000 Reduced 25.88%	2,864 $237,000
Q2 2022 Jul 22, 2022	SELL	$57.72 - $65.01 $14,487 - $16,317	-251 Reduced 6.1%	3,864 $239,000
Q4 2021 Jan 19, 2022	SELL	$64.88 - $73.64 $38,928 - $44,184	-600 Reduced 12.73%	4,115 $299,000
Q2 2021 Jul 29, 2021	SELL	$63.47 - $69.35 $12,694 - $13,869	-200 Reduced 4.07%	4,715 $325,000
Q1 2021 May 14, 2021	BUY	$60.0 - $68.46 $60,000 - $68,460	1,000 Added 25.54%	4,915 $318,000
Q4 2020 Feb 16, 2021	BUY	$56.65 - $64.55 $221,784 - $252,713	3,915 New	3,915 $228,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Signature Wealth Management Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Signature Wealth Management Partners, LLC with notifications on news.